Ads
related to: Psoriatic Arthritis and Arthritis- Treatment FAQs
Get Answers To Frequently Asked
Questions About Our Treatment.
- Explore Savings Options
Sign Up For Information, Updates,
& A $0 Co-Pay Savings Offer.
- Discussion Guide
Questions To Ask Before Seeing Your
Doctor To Talk About Treatment.
- Treatment Cost Info
Find Information On Paying For
Our Psoriatic Arthritis Treatment.
- Treatment FAQs
Search results
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure...
WROC Rochester· 5 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Harbor Investment Advisory LLC
ETF DAILY NEWS· 2 days agoHarbor Investment Advisory LLC increased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with ...
Johnson & Johnson (NYSE:JNJ) Issues FY24 Earnings Guidance
ETF DAILY NEWS· 6 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $10.57-10.72 for the period, compared to the consensus EPS ...
FDA approves Alvotech biosimilar of J&J top-selling drug Stelara (NYSE:TEVA)
Seeking Alpha· 3 days agoThe FDA has approved Alvotech’s biosimilar of Johnson & Johnson’s (JNJ) Stelara, with Teva hoping to...
INVESTOR INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx...
WPRI Providence· 6 days agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and reminds investors ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Tobam
ETF DAILY NEWS· 4 days agoTobam lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC ...
Dearborn Partners LLC Sells 439 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoDearborn Partners LLC trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...
VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc....
Morningstar· 3 days agoAttorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ( ...
YHB Investment Advisors Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 8 hours agoYHB Investment Advisors Inc. reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Ingalls & Snyder LLC Sells 4,104 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 8 hours agoIngalls & Snyder LLC reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Ads
related to: Psoriatic Arthritis and Arthritis